{"product_id":"the-science-of-adhd-isbn-9781118941249","title":"The Science of ADHD","description":"\u003cp\u003e\u003cb\u003eA comprehensive and evidence-based guide to understanding ADHD and its treatment \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eADHD remains one of the most widely misunderstood neurodevelopmental disorders, with debates surrounding its diagnosis, causes, and treatment continuing to evolve. \u003ci\u003eThe Science of ADHD\u003c\/i\u003e provides a clear, balanced, and up-to-date exploration of this complex condition. With an accessible narrative style, author Chris Chandler expertly navigates the latest research to present an objective look at ADHD's neuroscience, genetics, psychological theories, and treatment approaches.\u003c\/p\u003e \u003cp\u003eThe fully revised second edition reflects the latest advancements in the field, including updated diagnostic criteria and a nuanced discussion of ADHD as a neurodevelopmental disorder. New and expanded chapters address the impact of non-pharmacological treatments, ADHD's association with addiction, ongoing challenges in ADHD research, the broader implications of neurodiversity, and more. Throughout this edition, engaging discussions of genetics, neuroscience, and psychology enable readers to develop a deeper understanding of ADHD and its implications.\u003c\/p\u003e \u003cp\u003eEmpowering readers with the knowledge needed to make informed decisions, \u003ci\u003eThe Science of ADHD:\u003c\/i\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eDiscusses emerging research, treatment innovations, and ongoing questions in ADHD science\u003c\/li\u003e \u003cli\u003eBalances academic depth with readability, making complex concepts approachable for non-specialists and professionals alike\u003c\/li\u003e \u003cli\u003eOffers actionable insights for educators, clinicians, and parents to better support individuals with ADHD\u003c\/li\u003e \u003cli\u003eCovers pharmacological, non-pharmacological, and emerging treatment options, alongside critiques of current approaches\u003c\/li\u003e \u003cli\u003eFeatures real-life insights and experiences shared by individuals with ADHD and their family members\u003c\/li\u003e \u003cli\u003eIncludes a glossary and a well-organized layout to help readers navigate scientific terms and concepts effectively\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eBridging the gap between cutting-edge science and everyday experience, \u003ci\u003eThe Science of ADHD, Second Edition,\u003c\/i\u003e is ideal for undergraduate and postgraduate psychology and neuroscience courses focusing on developmental disorders or psychobiology. It is also a valuable reference for clinicians, educators, and policymakers seeking a research-backed understanding of ADHD to support individuals in diverse settings.\u003c\/p\u003e \u003cp\u003ePreface to the Second Edition xv\u003c\/p\u003e \u003cp\u003ePreface to the First Edition xvii\u003c\/p\u003e \u003cp\u003eAcknowledgments xxi\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 What Is ADHD? 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWhat Does ADHD Look Like and Who Has It? 2\u003c\/p\u003e \u003cp\u003eADHD – Two Faces of the Same Coin 3\u003c\/p\u003e \u003cp\u003eThe Negative Impact of ADHD 6\u003c\/p\u003e \u003cp\u003eWhat Is ADHD Like? 6\u003c\/p\u003e \u003cp\u003eAdult Male Personal Account A 11\u003c\/p\u003e \u003cp\u003eAdult Female Personal Account 15\u003c\/p\u003e \u003cp\u003eA Child’s Personal Account (Diagnosed at the Age of 8 Years) 18\u003c\/p\u003e \u003cp\u003eA Parent’s View 19\u003c\/p\u003e \u003cp\u003eAnother Parent’s View 22\u003c\/p\u003e \u003cp\u003eA Mother with ADHD’s Personal Account of Parenting a Daughter with ADHD 25\u003c\/p\u003e \u003cp\u003eAre There Any Positive Aspects to Having ADHD? 28\u003c\/p\u003e \u003cp\u003eADHD: Science and Society 31\u003c\/p\u003e \u003cp\u003eScience and Proof 32\u003c\/p\u003e \u003cp\u003eGood Science and Drug Development 38\u003c\/p\u003e \u003cp\u003eSummary 41\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Diagnosis, Epidemiology, and Comorbidity 43\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eA Short History of ADHD 44\u003c\/p\u003e \u003cp\u003eFormal Diagnosis 48\u003c\/p\u003e \u003cp\u003eDSM Criteria 51\u003c\/p\u003e \u003cp\u003eDSM vs. ICD 58\u003c\/p\u003e \u003cp\u003eIs ADHD Real? 65\u003c\/p\u003e \u003cp\u003eAdult ADHD 67\u003c\/p\u003e \u003cp\u003eIs Adult ADHD Real? 69\u003c\/p\u003e \u003cp\u003eDiagnosis and the Future Criteria 71\u003c\/p\u003e \u003cp\u003eAssessment 71\u003c\/p\u003e \u003cp\u003eRating Scales 73\u003c\/p\u003e \u003cp\u003eADHD Rating Scales: Children 74\u003c\/p\u003e \u003cp\u003eSNAP-IV, SKAMP, and SWAN 74\u003c\/p\u003e \u003cp\u003eADHD Rating Scale IV (ADHD RS IV) and ADHD RS 5 74\u003c\/p\u003e \u003cp\u003eConner’s Rating Scales – Revised (CRS-R) 74\u003c\/p\u003e \u003cp\u003eVanderbilt ADHD Teacher and Parent Rating Scales (VADTRS and VANPRS) 75\u003c\/p\u003e \u003cp\u003eADHD Symptoms Rating Scale 75\u003c\/p\u003e \u003cp\u003eAttention Deficit Disorder Evaluation Scale - Second Edition (addes 2) 75\u003c\/p\u003e \u003cp\u003eACTeRS - 2nd Edition 75\u003c\/p\u003e \u003cp\u003eBrown Attention-Deficit Disorder Scales for Children and Adolescents (BADDS) 75\u003c\/p\u003e \u003cp\u003eThe Child Behavior Checklist (CBCL) 76\u003c\/p\u003e \u003cp\u003eThe Strengths and Difficulties Questionnaire (SDQ) 76\u003c\/p\u003e \u003cp\u003eParental Account of Childhood Symptoms (PACS) 76\u003c\/p\u003e \u003cp\u003eWeiss Functional Impairment Rating Scale (WFIRS) 76\u003c\/p\u003e \u003cp\u003eADHD Rating Scales: Adults 76\u003c\/p\u003e \u003cp\u003eWender Utah Rating Scale (WURS) (See Also Adult ADHD) 77\u003c\/p\u003e \u003cp\u003eConner’s Adult ADHD Rating Scales (CAARS) 77\u003c\/p\u003e \u003cp\u003eBrown Adult ADD Scale 77\u003c\/p\u003e \u003cp\u003eThe Adult ADHD Self-Report Scale (ASRS) 77\u003c\/p\u003e \u003cp\u003eRating Scales: Summary 77\u003c\/p\u003e \u003cp\u003eEpidemiology 78\u003c\/p\u003e \u003cp\u003eThe Cultural Context of Diagnosis 80\u003c\/p\u003e \u003cp\u003eSex Differences 81\u003c\/p\u003e \u003cp\u003eOver- and Underdiagnosis 82\u003c\/p\u003e \u003cp\u003ePrognosis 83\u003c\/p\u003e \u003cp\u003eComorbidity – Not Just ADHD 85\u003c\/p\u003e \u003cp\u003eAutism and ADHD 87\u003c\/p\u003e \u003cp\u003ePrevalence of ASD with and Without ADHD 88\u003c\/p\u003e \u003cp\u003eImplications of ASD and ADHD 88\u003c\/p\u003e \u003cp\u003eSummary 88\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Causality and the Environmental Hypotheses of ADHD 91\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eWhat Causes ADHD? 91\u003c\/p\u003e \u003cp\u003eCausality 92\u003c\/p\u003e \u003cp\u003eAnimal Models of ADHD 93\u003c\/p\u003e \u003cp\u003eGenetic Models 96\u003c\/p\u003e \u003cp\u003eAlpha-synuclein Lacking Mice 98\u003c\/p\u003e \u003cp\u003ePhysical Trauma\/Environment 98\u003c\/p\u003e \u003cp\u003eAnoxia\/Hypoxia in Neonatal Rodents 99\u003c\/p\u003e \u003cp\u003eX-radiation of Neonatal Rodents 99\u003c\/p\u003e \u003cp\u003eCerebellar Stunting Model of ADHD 99\u003c\/p\u003e \u003cp\u003eMaternally Stressed Mice 99\u003c\/p\u003e \u003cp\u003ePrenatal Ethanol Exposure 100\u003c\/p\u003e \u003cp\u003eWhat Can Animal Models Tell Us About ADHD? 100\u003c\/p\u003e \u003cp\u003eThe Environment 100\u003c\/p\u003e \u003cp\u003eThe Environment in Utero: Pregnancy, Birth Complications, and Teratology 101\u003c\/p\u003e \u003cp\u003ePregnancy and Birth Complications 101\u003c\/p\u003e \u003cp\u003eTeratology: Are Neurotoxins a Possible Cause? 102\u003c\/p\u003e \u003cp\u003eMaternal Smoking 103\u003c\/p\u003e \u003cp\u003eMaternal Alcohol Consumption 104\u003c\/p\u003e \u003cp\u003eLow Birth Weight and ADHD 106\u003c\/p\u003e \u003cp\u003eTrace Elements in ADHD 107\u003c\/p\u003e \u003cp\u003eFood Additives, Allergies, and Responses 108\u003c\/p\u003e \u003cp\u003eFatty Acids in ADHD 109\u003c\/p\u003e \u003cp\u003eTelevision and Computer Games 111\u003c\/p\u003e \u003cp\u003eThe Environment: Blame Culture, Agency, Free Will, Families, and Society 113\u003c\/p\u003e \u003cp\u003eSummary 115\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Neuropsychological Theories of ADHD 117\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eExecutive Functions 117\u003c\/p\u003e \u003cp\u003eNeuropsychological Tests and the Generation of Theories 118\u003c\/p\u003e \u003cp\u003eTheory of Mind 122\u003c\/p\u003e \u003cp\u003eImpulse Control: Impulsivity and Behavioral\/Response Inhibition 125\u003c\/p\u003e \u003cp\u003eBarkley’s Neuropsychological Account – Behavioral Inhibition 127\u003c\/p\u003e \u003cp\u003eMeasures of Behavioral Inhibition and ADHD 129\u003c\/p\u003e \u003cp\u003eMotivational Inhibition 138\u003c\/p\u003e \u003cp\u003eWorking Memory 138\u003c\/p\u003e \u003cp\u003eBarkley’s Updated Executive Functioning Model 143\u003c\/p\u003e \u003cp\u003eAlerting, Orienting, and Executive Functioning – Separate Circuits in Adhd 144\u003c\/p\u003e \u003cp\u003eThe Supervisory Attentional System 146\u003c\/p\u003e \u003cp\u003eBrown’s Executive Functioning Model 147\u003c\/p\u003e \u003cp\u003eCognitive–Energetic Model 148\u003c\/p\u003e \u003cp\u003eA Behavioral Neuroenergetics Theory of ADHD 149\u003c\/p\u003e \u003cp\u003eSummary 151\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 The Genetics of ADHD 153\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe Evidence for (and Against) ADHD as a Genetically Inherited Disorder 154\u003c\/p\u003e \u003cp\u003eBehavioral Genetics 154\u003c\/p\u003e \u003cp\u003eTwins 154\u003c\/p\u003e \u003cp\u003eEvolutionary Explanations for ADHD and Its Continuation 158\u003c\/p\u003e \u003cp\u003eEvolutionary Psychology, ADHD, and Specific Genes 162\u003c\/p\u003e \u003cp\u003eMolecular Genetics 164\u003c\/p\u003e \u003cp\u003eA Brief Lesson on Genetics 164\u003c\/p\u003e \u003cp\u003eGenetic Variation 167\u003c\/p\u003e \u003cp\u003ePolymorphisms 167\u003c\/p\u003e \u003cp\u003eVariable Number Tandem Repeats 168\u003c\/p\u003e \u003cp\u003eGenetic Markers 168\u003c\/p\u003e \u003cp\u003eEpigenetics 168\u003c\/p\u003e \u003cp\u003eExploring Genes in ADHD 170\u003c\/p\u003e \u003cp\u003eDopamine Genes and ADHD 171\u003c\/p\u003e \u003cp\u003eDopamine Transporter Gene 171\u003c\/p\u003e \u003cp\u003eDRD4 Gene 172\u003c\/p\u003e \u003cp\u003eDRD1 Gene 173\u003c\/p\u003e \u003cp\u003eDRD2 Gene 173\u003c\/p\u003e \u003cp\u003eDRD3 Gene 173\u003c\/p\u003e \u003cp\u003eDRD5 Gene 174\u003c\/p\u003e \u003cp\u003eOther Non-DA or Non-DA Specific Related Genes 174\u003c\/p\u003e \u003cp\u003eCatechol-O-Methyltransferase (COMT) Gene 174\u003c\/p\u003e \u003cp\u003eSNAP25 Gene 175\u003c\/p\u003e \u003cp\u003eTH (Tyrosine Hydroxylase), DOPA Decarboxylase, and DBH (Dopamine Beta-Hydroxylase) Genes 175\u003c\/p\u003e \u003cp\u003eMAOA (Monoamine Oxidase A) Genes 176\u003c\/p\u003e \u003cp\u003eBDNF (Brain-Derived Neurotrophic Factor) 176\u003c\/p\u003e \u003cp\u003eNoradrenergic Genes 176\u003c\/p\u003e \u003cp\u003eSerotonergic Genes 177\u003c\/p\u003e \u003cp\u003eIs There a Gene for ADHD? 177\u003c\/p\u003e \u003cp\u003eAdmixture in the Genetics of ADHD 180\u003c\/p\u003e \u003cp\u003eCan Genes Explain the Sex Difference in ADHD (If There Is a Difference)? 181\u003c\/p\u003e \u003cp\u003eThe Endophenotype 183\u003c\/p\u003e \u003cp\u003eSummary 185\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 The Neuroscience of ADHD 187\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe Brain: A Brief Guide to Development and Neuroanatomy 187\u003c\/p\u003e \u003cp\u003eDevelopmental Changes in the Brain 188\u003c\/p\u003e \u003cp\u003eRegions of the Brain 190\u003c\/p\u003e \u003cp\u003eThe Cortex 191\u003c\/p\u003e \u003cp\u003eThe Limbic System 191\u003c\/p\u003e \u003cp\u003eThe Basal Ganglia 191\u003c\/p\u003e \u003cp\u003eCerebellum 194\u003c\/p\u003e \u003cp\u003eA Brief Account of Imaging the Brain 194\u003c\/p\u003e \u003cp\u003eThe Brain in ADHD 196\u003c\/p\u003e \u003cp\u003eStructural Changes 196\u003c\/p\u003e \u003cp\u003eGray and White Matter 196\u003c\/p\u003e \u003cp\u003eThe Cortex 197\u003c\/p\u003e \u003cp\u003eThe Frontal Lobes 198\u003c\/p\u003e \u003cp\u003eThe Parietal Lobe 198\u003c\/p\u003e \u003cp\u003eBasal Ganglia 198\u003c\/p\u003e \u003cp\u003eCerebellum 199\u003c\/p\u003e \u003cp\u003eFunctional Significance 200\u003c\/p\u003e \u003cp\u003eFunctional Imaging of ADHD 200\u003c\/p\u003e \u003cp\u003ePsychophysiological Studies 201\u003c\/p\u003e \u003cp\u003eConnectivity in ADHD 202\u003c\/p\u003e \u003cp\u003eThe Fronto-striatal Circuits 203\u003c\/p\u003e \u003cp\u003eFronto-parietal Circuits 205\u003c\/p\u003e \u003cp\u003eCorticocerebellar Circuits 205\u003c\/p\u003e \u003cp\u003eDefault Mode Network and Task-Positive Networks in ADHD 205\u003c\/p\u003e \u003cp\u003eSummary 208\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Psychostimulant Medication for ADHD: From Treatment to Theory (and Back Again) 211\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eA Brief Review of the Neuropharmacology 211\u003c\/p\u003e \u003cp\u003eElectrical Communication 212\u003c\/p\u003e \u003cp\u003eSynaptic Transmission 214\u003c\/p\u003e \u003cp\u003ePharmacotherapy in ADHD 218\u003c\/p\u003e \u003cp\u003eThe Pharmacology and Efficacy of Psychostimulants used in treating ADHD 221\u003c\/p\u003e \u003cp\u003eMethylphenidate 222\u003c\/p\u003e \u003cp\u003ePharmacology 222\u003c\/p\u003e \u003cp\u003eAmphetamine 227\u003c\/p\u003e \u003cp\u003ePharmacology 227\u003c\/p\u003e \u003cp\u003eClinical Effects of Amphetamine and Methylphenidate 229\u003c\/p\u003e \u003cp\u003eThe MTA Study 232\u003c\/p\u003e \u003cp\u003eOther Studies and Neurocognitive Processes 237\u003c\/p\u003e \u003cp\u003eSide Effects and Concerns with Amphetamine and Methylphenidate 237\u003c\/p\u003e \u003cp\u003eOther Drugs that Increase Dopamine Levels 240\u003c\/p\u003e \u003cp\u003eL-Dopa 240\u003c\/p\u003e \u003cp\u003eApomorphine 241\u003c\/p\u003e \u003cp\u003eBromocriptine 241\u003c\/p\u003e \u003cp\u003eMonoamine Oxidase Inhibitors 242\u003c\/p\u003e \u003cp\u003ePemoline 243\u003c\/p\u003e \u003cp\u003ePharmacology 243\u003c\/p\u003e \u003cp\u003eClinical Effects 243\u003c\/p\u003e \u003cp\u003eSide Effects 243\u003c\/p\u003e \u003cp\u003eNicotine 244\u003c\/p\u003e \u003cp\u003ePharmacology 244\u003c\/p\u003e \u003cp\u003eClinical Effects 244\u003c\/p\u003e \u003cp\u003eTolerance and Withdrawal 245\u003c\/p\u003e \u003cp\u003ePlacebo Effects in ADHD 246\u003c\/p\u003e \u003cp\u003ePsychopharmacology: From Treatment to Theory 248\u003c\/p\u003e \u003cp\u003eHypo\/Hyperfunctioning DA in ADHD 249\u003c\/p\u003e \u003cp\u003eGrace’s Tonic and Phasic Account of ADHD 250\u003c\/p\u003e \u003cp\u003eA Dynamic Developmental Theory of ADHD 252\u003c\/p\u003e \u003cp\u003eThe Rate-dependent Hypothesis and the Effects of Psychostimulants 253\u003c\/p\u003e \u003cp\u003eExtending the Theory to Norepinephrine 255\u003c\/p\u003e \u003cp\u003eSummary 255\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Non-stimulant Medications and Non-pharmacological Treatments 257\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNon-stimulant Medications 257\u003c\/p\u003e \u003cp\u003eAtomoxetine 258\u003c\/p\u003e \u003cp\u003eViloxazine 262\u003c\/p\u003e \u003cp\u003eModafinil 262\u003c\/p\u003e \u003cp\u003eClonidine and Guanfacine 264\u003c\/p\u003e \u003cp\u003eCentanafadine: A Mixed Dopamine, Norepinephrine, and Serotonin-Based Drug 266\u003c\/p\u003e \u003cp\u003eHow Do These Drugs Fit into Theoretical Accounts of ADHD? 266\u003c\/p\u003e \u003cp\u003eNon-pharmacological Treatments 268\u003c\/p\u003e \u003cp\u003eNeurotherapeutics 268\u003c\/p\u003e \u003cp\u003eNeurofeedback 268\u003c\/p\u003e \u003cp\u003eBrain Stimulation 270\u003c\/p\u003e \u003cp\u003eBehavioral Therapies 272\u003c\/p\u003e \u003cp\u003eCognitive Behavioral Therapy (CBT) 273\u003c\/p\u003e \u003cp\u003eOther Behavioral Therapies 276\u003c\/p\u003e \u003cp\u003eAlternative Treatments 277\u003c\/p\u003e \u003cp\u003eSummary 278\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Addiction, Reward, and ADHD 279\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAddiction 279\u003c\/p\u003e \u003cp\u003eThe Neuropsychopharmacology of Addiction 280\u003c\/p\u003e \u003cp\u003eAddiction in ADHD 284\u003c\/p\u003e \u003cp\u003eAre ADHD Symptoms Subtypes Linked to Any Specific Drugs? 286\u003c\/p\u003e \u003cp\u003eAmphetamines, Methylphenidate, and Addiction 288\u003c\/p\u003e \u003cp\u003eMethylphenidate Treatment and Addiction 290\u003c\/p\u003e \u003cp\u003eDrugs, Cannabis, and Psychiatry 293\u003c\/p\u003e \u003cp\u003ePsychedelics, Endocannabinoids, and CBD: A New Treatment Strand for ADHD? 294\u003c\/p\u003e \u003cp\u003eSlow-Release Formulations and the Treatment of Cocaine and Amphetamine Addiction 295\u003c\/p\u003e \u003cp\u003eTheories of ADHD Based on DA Reward Pathways 298\u003c\/p\u003e \u003cp\u003eMethylphenidate and Long-term Neural Changes: Sensitization 298\u003c\/p\u003e \u003cp\u003eReward Deficiency in ADHD: Theory and Evidence 300\u003c\/p\u003e \u003cp\u003eReward Prediction Error 302\u003c\/p\u003e \u003cp\u003eThe Dopamine Transfer Deficit Hypothesis of ADHD 304\u003c\/p\u003e \u003cp\u003eThe Dual-Pathway Model of ADHD 305\u003c\/p\u003e \u003cp\u003eImpulsivity in SUD and ADHD (Revisited) 308\u003c\/p\u003e \u003cp\u003eSummary 309\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 The Past, Present, and Future Science of ADHD 311\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eToward a Better Understanding and Treatment of ADHD 316\u003c\/p\u003e \u003cp\u003eWhat Do the NICE Guidelines on ADHD Really State? 317\u003c\/p\u003e \u003cp\u003eGlossary 321\u003c\/p\u003e \u003cp\u003eReferences 337\u003c\/p\u003e \u003cp\u003eIndex 507\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eCHRIS CHANDLER\u003c\/b\u003e is Professor of Psychology at London Metropolitan University, where he teaches psychobiology and addiction at both undergraduate and postgraduate levels. An expert in the neuropsychology of ADHD and addiction, Chandler’s research explores the role of dopamine in behavior and the psychobiological aspects of addiction. He is also the author of \u003ci\u003ePsychobiology\u003c\/i\u003e and \u003ci\u003eAddiction: A Biopsychosocial Perspective      \u003c\/i\u003e (co-authored with Anita Andrews) and numerous peer-reviewed articles.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eA Clear and Comprehensive Guide to Understanding ADHD\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eIn \u003ci\u003eThe Science of ADHD,\u003c\/i\u003e Chris Chandler provides a thorough and accessible exploration of attention-deficit\/hyperactivity disorder (ADHD), shedding light on its complex scientific underpinnings and practical implications. With real-life insights and experiences shared by individuals with ADHD, this guide offers a research-based perspective on ADHD—breaking down complicated concepts, dispelling myths, and addressing common questions about the disorder’s nature and treatment. \u003c\/p\u003e\u003cp\u003eIncorporating the latest research findings and diagnostic criteria, \u003ci\u003eThe Science of ADHD\u003c\/i\u003e covers the full range of biological, genetic, and psychological dimensions. This second edition offers a nuanced look at ADHD’s causes, symptoms, and management strategies, featuring expanded chapters discussing the impact of non-pharmacological treatments, ADHD’s association with addiction, ongoing challenges in ADHD research, and much more. \u003c\/p\u003e\u003cp\u003eHelping you better understand the nuances of ADHD and its varied presentations across ages and environments, \u003ci\u003eThe Science of ADHD\u003c\/i\u003e is a must-have guide for parents, educators, clinicians, and anyone impacted by ADHD. It is also an essential text for psychology and education students seeking a foundational understanding of ADHD, fitting seamlessly into undergraduate and postgraduate courses in psychology, counseling, and special education.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990335733989,"sku":"NP9781118941249","price":44.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118941249.jpg?v=1761787405","url":"https:\/\/k12savings.com\/es\/products\/the-science-of-adhd-isbn-9781118941249","provider":"K12savings","version":"1.0","type":"link"}